Study: Lung Cancer Pill Reduces Death Risk By 50%.
(CTN News) - Clinical trial data released at the annual conference of Lung Cancer specialists in Chicago has revealed that a pill called.............
Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(CTN News) - Clinical trial data released at the annual conference of Lung Cancer specialists in Chicago has revealed that a pill called.............
Truqap (capivasertib) plus fulvestrant is approved for adults with HR+/HER2- locally advanced or metastatic breast cancer with PIK3CA/AKT1/PTEN-alterations.
Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell. UK retail sales declined last month...
AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer. The...
Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK. The FTSE 100 index opened up 50.90 points, 0.7%, at 7,461.07. The FTSE 250 was...